Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer

Pathology International

Volumn 64, Issue 11, 2014, Pages 560-568

  Matsubara, Daisuke ^a,b   Kishaba, Yuka ^b   Yoshimoto, Taichiro ^b   Sakuma, Yuji ^b   Sakatani, Takashi ^b   Tamura, Tomoko ^b   Endo, Shunsuke ^b   Sugiyama, Yukihiko ^b   Murakami, Yoshinori ^a   Niki, Toshiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

E cadherin; EMT; Lung adenocarcinoma; ZEB1

Indexed keywords

TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; CADHERINS; HOMEODOMAIN PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; ZEB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG METASTASIS; MALE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINDLE CELL; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84923379376     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12214     Document Type: Article

References (20)

1. Statistics and Information Department. Vital Statistics, 2000. Tokyo: Ministry of Health, Labor and Welfare, 2001.
2. Jemal A, Siegel R, Ward E etal. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
3. Naruke T, Tsuchiya R, Kondo H etal. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: The Japanese experience. Ann Thorac Surg 2001; 71: 1759-1764.
4. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
5. Mani SA, Guo W, Liao MJ etal. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
6. Sequist LV, Waltman BA, Dias-Santagata D etal. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011; 3: 75ra26.
7. Yang J, Mani SA, Donaher JL etal. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939.
8. Moreno-Bueno G, Cubillo E, Sarrió D etal. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 2006; 66: 9543-9556.
9. Ohira T, Gemmill RM, Ferguson K etal. WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci U S A 2003; 100: 10429-10434.
10. Takeyama Y, Sato M, Horio M etal. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 2010; 296: 216-224.
11. Clarhaut J, Gemmill RM, Potiron VA etal. ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia 2009; 11: 157-166.
12. Ceppi P, Mudduluru G, Kumarswamy R etal. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 2010; 8: 1207-1216.
13. Goldstraw P, Crowley J, Chansky K etal. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714.
14. Travis WD, Brambilla E, Noguchi M etal. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
15. Matsubara D, Morikawa T, Goto A etal. Subepithelial myofibroblast in lung adenocarcinoma: A histological indicator of excellent prognosis. Mod Pathol 2009; 22: 776-785.
16. Gemmill RM, Roche J, Potiron VA etal. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 2011; 300: 66-78.
17. Onder TT, Gupta PB, Mani SA etal. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654.
18. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97-110.
19. Oshiro R, Yamamoto H, Takahashi H etal. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer. Cancer Sci 2012; 103: 1155-1164.
20. Matsubara D, Kishaba Y, Ishikawa S etal. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features. Cancer Sci 2013; 104: 266-273.